Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and welcome to another working week. Once again, another weekend respite has come and gone. Hopefully, you enjoyed yourselves. In any event, that familiar routine of meetings and deadlines has now resumed. To cope, we are brewing a cup of stimulation, although our choice today is a spot of tea. A little variety can be a good thing, yes? So please join us as we hunker down for a busy day. As always, here are some items of interest. Hope your day goes well and do stay in touch... Shire To Pay $4.2 Billion For ViroPharma To Add Orphan Drugs (Bloomberg News) J&J And Amazon Clash Over Third-Party Product Sales (The Wall Street Journal) Novartis To Sell Blood Diagnostics Unit For $1.7B To Grifols (Bloomberg News) AstraZeneca To Invest $190M At UK Facility To Make Cancer Drug (Reuters) Vivus Diet Pill Helped Diabetics Lose Weight In Study (MedPage Today) Daiichi Sankyo And Singhs Reach Arbitration Over Ranbaxy Deal (Economic Times) Indian Regulator Cuts Prices Of 63 Essential Drugs (The Times of India) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs